TRT Fertility Safety: Questions Before Treatment

Testosterone replacement therapy can substantially reduce sperm production. In some men, sperm concentration falls into a severely low range or no sperm are found in the ejaculate at all. In others, sperm production continues. You cannot determine your current sperm count—or know exactly how strongly TRT will suppress it—from age, testosterone level, symptoms, testicle size, semen appearance, or the type of TRT a clinic sells.

That uncertainty is the point: TRT is not fertility-safe, but it is not reliable birth control either. Recovery after stopping testosterone is common, often takes months, and cannot be promised on an individual timeline.

Trying to conceive now? Major endocrine and urology guidelines recommend against exogenous testosterone when fertility is an active or near-term goal. Do not start TRT based only on a sales-clinic promise that hCG will “protect” your sperm. If you already take prescribed testosterone, do not stop or change it solely because of this page. Contact the prescriber and a reproductive urologist or other male-fertility specialist for a coordinated plan.

Medical review status: Evidence-cited educational content; not independently medically reviewed. This page does not provide a fertility-drug protocol or medication doses.

On this page

• The answer in one minute
• How TRT suppresses sperm production
• What major guidelines say
• Whether fertility recovers after TRT
• What to do before starting TRT
• Fertility-conscious treatment approaches
• What to do if you already take TRT
• Provider standards and red flags
• Frequently asked questions

The answer in one minute

• TRT can suppress sperm production. External testosterone lowers the brain and pituitary signals—LH and FSH—that the testes need to maintain high intratesticular testosterone and make sperm.
• The effect varies. Some men develop azoospermia, meaning no sperm are detected in the ejaculate. Others retain enough sperm for pregnancy to remain possible.
• TRT is not contraception. A partner can become pregnant while you are taking testosterone.
• Stopping TRT often allows sperm to return, but recovery is not guaranteed. The timeline can range from months to longer than a year, and returning sperm is not the same as returning to your old baseline or achieving pregnancy.
• Do not use blood testosterone as a fertility test. A normal or high serum testosterone level on TRT says nothing reliable about sperm count.
• A semen analysis is the key test. If the first result is abnormal, guidelines note that repeat testing is important because semen measurements vary from sample to sample.
• hCG, clomiphene, aromatase inhibitors, FSH, and other treatments are not interchangeable. Their usefulness depends on why testosterone is low, whether the pituitary and testes can respond, current semen results, and the time available to conceive.
• No add-on makes TRT universally fertility-neutral. Small studies support a biological rationale for hCG during TRT, but they do not prove guaranteed sperm preservation or pregnancy.
• The safest time to discuss fertility is before the first testosterone dose. That is when baseline semen testing and sperm banking remain simplest.

What “fertility” means on this page

Several terms are often treated as if they mean the same thing. They do not.

A semen analysis measures important fertility markers, but it cannot guarantee or rule out pregnancy in every case. Pregnancy also depends on timing, sexual and ejaculatory function, the reproductive health of both partners, and chance.

How TRT suppresses sperm production

Natural testosterone production and sperm production are controlled by the hypothalamic-pituitary-gonadal axis:

1. The hypothalamus releases gonadotropin-releasing hormone, or GnRH.
2. GnRH signals the pituitary gland to release luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH.
3. LH signals Leydig cells in the testes to produce testosterone.
4. FSH acts with high testosterone concentrations inside the testes to support Sertoli cells and spermatogenesis.

Exogenous testosterone changes that feedback loop. When testosterone arrives from an injection, gel, patch, pellet, oral product, or another external source, the brain reads the circulating level as evidence that less stimulation is needed. GnRH, LH, and FSH can fall. The testes then receive less of the signaling needed for their own testosterone production and sperm production.

The result can look counterintuitive: blood testosterone may be normal or high while testosterone inside the testes and sperm production are both suppressed. Raising the TRT dose does not solve that problem. It can deepen negative feedback.

The AUA/ASRM male-infertility guideline explains that exogenous testosterone can inhibit gonadotropin secretion and that spermatogenesis may decrease or cease, resulting in azoospermia. The Endocrine Society recommends against starting testosterone in men planning fertility in the near term. (AUA/ASRM guideline, Part II; Endocrine Society guideline)

Can every form of TRT affect fertility?

Yes. Any systemic exogenous testosterone can suppress LH and FSH, including:

• testosterone injections;
• testosterone gels and creams;
• patches;
• pellets;
• oral testosterone products; and
• nonprescribed testosterone or anabolic-androgenic steroids.

The speed and degree of suppression can differ by drug, dose, schedule, duration, baseline testicular function, and individual response. That does not make one standard TRT route reliably fertility-safe. Switching from injections to gel, for example, should not be presented as a proven way to protect sperm.

A semen analysis—not a formulation claim—is what shows what is happening in a specific patient. For practical differences between common delivery routes, see TRT injections vs. gel; neither route should be treated as fertility-neutral.

What major medical guidelines say

The major guidelines are unusually consistent on the central point.

Sources: Endocrine Society, AUA Testosterone Deficiency Guideline, AUA/ASRM Male Infertility Guideline, and EAU Sexual and Reproductive Health Guideline.

These recommendations do not mean every man who takes TRT becomes permanently infertile. They mean the suppression is foreseeable, potentially severe, and avoidable when pregnancy is the immediate priority.

TRT is not reliable birth control

TRT has been studied as part of experimental hormonal male-contraception regimens because it can suppress sperm. That does not make ordinary TRT an approved or dependable contraceptive.

There are three reasons not to rely on it:

1. Not every man reaches azoospermia.
2. Suppression is not immediate.
3. Sperm production can change over time, including during dose changes or missed treatment.

Pregnancy can occur while a man is using testosterone. Anyone who does not want a pregnancy should use an established contraceptive method rather than assuming TRT has made conception impossible.

A semen analysis showing azoospermia is only a snapshot of the tested sample. It is not permission to treat TRT as permanent sterilization, and it does not prove that sperm will remain absent indefinitely.

How likely is TRT to lower sperm count?

There is no honest single percentage that applies to every man on routine TRT.

Studies differ in the testosterone product, dose, duration, participant age, baseline fertility, and definition of suppression. Hormonal-contraception trials enrolled mostly healthy men with normal reproductive function. TRT patients often have a medical reason for low testosterone, may be older, and may use treatment for years. Those populations are not interchangeable.

The clinically useful conclusion is simpler:

• substantial suppression is common enough that every prospective TRT patient should be counseled;
• azoospermia is possible but not inevitable;
• no symptom or blood test can substitute for semen testing; and
• the absence of an immediate fertility plan does not eliminate the need to discuss future goals.

Is infertility from TRT reversible?

Often, but not always on the timeline a patient wants—and not always back to the prior baseline.

The best-known recovery estimates come from a 2006 integrated analysis of 30 hormonal male-contraception studies involving 1,549 healthy men. After hormones were stopped, the modeled probability of recovering to the study threshold of 20 million sperm per milliliter was:

(Liu et al., The Lancet, 2006)

Those numbers are frequently quoted as if they guarantee recovery after TRT. They do not. The study population and endpoint matter:

• Participants were generally healthy men enrolled in controlled contraceptive studies, not a representative sample of men with years of medically treated hypogonadism.
• Exposure was defined and time-limited.
• The endpoint was reaching a sperm-concentration threshold, not returning to each man’s baseline.
• The endpoint was not natural pregnancy, live birth, or freedom from fertility treatment.
• The “100% by 24 months” estimate should not be converted into a promise to an individual patient.

A retrospective fertility-clinic study provides a more cautionary real-world view. It followed 66 men with testosterone-associated infertility after testosterone was stopped and a clinician-directed hCG/SERM recovery regimen was used. Seventy percent reached a total motile sperm count above 5 million within 12 months. Older age and longer testosterone exposure predicted a slower response. (Kohn et al., 2017)

That study also has limits. It was retrospective, involved specialist treatment, used a relatively modest semen threshold, and did not prove that the regimen caused every recovery or that reaching the threshold produced a pregnancy.

Recovery can mean several different things

When a clinic says fertility “comes back,” ask what outcome it means:

• any sperm became detectable;
• sperm concentration crossed a laboratory threshold;
• total motile sperm count became adequate for IUI;
• semen returned to the pre-TRT baseline;
• natural pregnancy occurred; or
• a live birth occurred.

Those are not equivalent outcomes.

Factors that can change the recovery timeline

Recovery may be affected by:

• sperm production before TRT;
• the underlying cause of low testosterone;
• age;
• duration and intensity of testosterone or anabolic-steroid exposure;
• prior testicular injury, undescended testes, chemotherapy, radiation, infection, or surgery;
• pituitary or hypothalamic disease;
• genetic causes of impaired spermatogenesis;
• other medications or hormones;
• general metabolic health; and
• the reproductive timeline and health of the pregnancy partner.

A man who had impaired spermatogenesis before TRT may recover from medication-induced suppression without ever reaching a normal semen profile. Without a baseline semen analysis, it can be impossible to know how much of a later abnormality existed before treatment.

Low testosterone and infertility are related—but not in one simple way

Low serum testosterone does not automatically mean a man is infertile. Infertility does not automatically mean serum testosterone is low. The cause matters.

Primary hypogonadism

In primary hypogonadism, the testes do not respond normally. LH and FSH may be elevated because the pituitary is trying to stimulate them. Conditions such as significant testicular injury, some genetic disorders, chemotherapy, or other direct testicular disease can impair testosterone and sperm production together.

Giving external testosterone may improve some androgen-deficiency symptoms, but it does not repair sperm-producing tissue and can further suppress the remaining pituitary drive.

Secondary hypogonadism

In secondary hypogonadism, the hypothalamus or pituitary does not provide adequate stimulation. LH and FSH may be low or inappropriately normal. Depending on the cause and whether the testes can respond, specialist-directed treatment with hCG, FSH, or pulsatile GnRH may stimulate endogenous testosterone and spermatogenesis.

AUA/ASRM guidance says hypogonadotropic hypogonadism should be evaluated for its cause and treated according to that diagnosis. It encourages referral to an endocrinologist or male reproductive specialist. (AUA/ASRM guideline, Part II)

Reversible or functional contributors

Obesity, certain medications—including opioids and corticosteroids—and other health conditions can contribute to low testosterone. The Endocrine Society’s 2026 statement emphasizes accurate diagnosis and ruling out reversible contributors rather than treating symptoms or one low result in isolation. It identifies weight loss as the usual first-line approach when obesity is the only identified cause of appropriately diagnosed hypogonadism. (Endocrine Society 2026 statement)

This is one reason fertility-conscious care begins with diagnosis. “Your testosterone is low” is not a complete explanation of why it is low, whether TRT is the best first treatment, or what will happen to sperm.

What to do before starting TRT when future fertility may matter

A fertility discussion should happen before the prescription, even when pregnancy is several years away or the patient is unsure whether he wants children.

1. State the fertility goal plainly

Tell the clinician whether you are:

• actively trying to conceive;
• planning to try in the near future;
• unsure but want to preserve the option;
• finished having children; or
• relying on TRT as if it were contraception.

The answer can change the entire treatment path. A checkbox asking “Do you want children?” without a conversation about timing is not enough.

2. Confirm that hypogonadism has been properly diagnosed

The Endocrine Society recommends diagnosing hypogonadism only when symptoms or signs are present and testosterone is unequivocally and consistently low. It recommends repeating a morning fasting total-testosterone measurement and evaluating the cause, including distinguishing primary from secondary hypogonadism with LH and FSH. (Endocrine Society guideline)

A fertility-aware workup may include, as clinically indicated:

• repeat morning testosterone testing;
• LH and FSH;
• prolactin when the history and hormone pattern suggest it;
• a medication and substance review;
• a reproductive and sexual history;
• physical examination; and
• targeted testing for pituitary, testicular, genetic, or systemic causes.

A page on the internet cannot determine which tests a particular patient needs. See TRT blood tests for the broader monitoring framework; those blood tests do not replace semen analysis when fertility is the question.

3. Get a baseline semen analysis

A baseline semen analysis answers two questions TRT blood work cannot:

1. Are sperm present before treatment?
2. What was the approximate pre-treatment semen profile if fertility becomes a problem later?

The AUA/ASRM guideline says an initial male fertility evaluation should include a reproductive history and one or more semen analyses. Because semen values vary substantially from one ejaculate to another, it says at least two analyses, ideally at least one month apart, are important when the first test is abnormal. (AUA/ASRM guideline, Part I)

One normal test does not guarantee future pregnancy, and one abnormal test does not automatically establish permanent infertility. Abnormal results should be interpreted by a male reproductive expert rather than a TRT salesperson.

4. Discuss sperm cryopreservation before suppression

Ejaculated-semen cryopreservation is an established fertility-preservation technology. ASRM notes that multiple samples are ideal when possible because they can preserve more options for future IUI or IVF. (ASRM fertility-preservation opinion, 2026)

That committee opinion focuses broadly on medical indications and gonadotoxic treatment; it does not require every man considering TRT to bank sperm. For TRT, banking is a risk-management decision based on fertility goals, baseline results, age, treatment urgency, cost, and comfort with future assisted reproduction.

Questions to ask a sperm bank or fertility clinic include:

• How many collections are recommended for my semen profile?
• What testing is included before freezing?
• How many vials or treatment attempts might the sample support?
• Is the sample likely to be usable for IUI, IVF, or only ICSI?
• What are collection, processing, annual storage, transfer, and withdrawal fees?
• What happens if the storage company closes or I move the sample?
• Who controls disposition after death, divorce, nonpayment, or loss of capacity?

Banking sperm does not guarantee a future pregnancy. It preserves a sample and an option. See the broader TRT cost guide when estimating fertility-related expenses that a basic TRT membership may not include.

5. Choose a provider that can coordinate reproductive care

A general TRT clinic and a reproductive-urology practice do different jobs. A clinic can be competent at testosterone management and still be the wrong lead clinician for active fertility treatment.

When sperm preservation or pregnancy is a priority, look for access to:

• a reproductive urologist, male-fertility urologist, or andrologist;
• an endocrinologist when pituitary or hypothalamic disease is possible;
• a laboratory experienced in formal semen analysis; and
• a reproductive endocrinology and infertility clinic when couple-level treatment or ART may be needed.

A practical decision table

Fertility-conscious treatment approaches a clinician may consider

There is no universal “best fertility protocol.” The right approach depends on whether the problem is primary or secondary hypogonadism, whether sperm are present, how soon pregnancy is desired, symptom severity, prior treatment, and the pregnancy partner’s reproductive timeline.

The options below are educational categories, not instructions to take or combine prescription drugs.

The AUA/ASRM guideline conditionally allows clinicians to use aromatase inhibitors, hCG, SERMs, or combinations in selected infertile men with low serum testosterone. The evidence level is Grade C, meaning confidence is limited and the choice depends heavily on the patient’s circumstances. (AUA/ASRM guideline, Part II)

Clomiphene is off-label in men

Clomiphene is widely discussed online as a “fertility-safe TRT alternative,” but that phrase compresses several uncertainties.

The FDA labeling for clomiphene is directed at ovulatory dysfunction, not male hypogonadism or male infertility. The label states that adequate, well-controlled studies have not demonstrated effectiveness for male infertility. It also warns that visual disturbances can occur and that prolonged or potentially irreversible disturbances have been reported. (DailyMed clomiphene label)

That does not mean clomiphene never helps men. It means a clinic should disclose the off-label use, explain why the patient’s hormone pattern makes a response plausible, discuss uncertainties and adverse effects, and monitor more than a testosterone number.

hCG has a real medical role—but “hCG protects fertility” is too absolute

The FDA label for Pregnyl, an hCG product, includes selected cases of male hypogonadotropic hypogonadism. The label explains that hCG acts similarly to LH and stimulates Leydig cells to produce androgens. It does not label hCG as a universal add-on that guarantees fertility during TRT. (DailyMed Pregnyl label)

That distinction matters. The use of a drug can be medically reasonable even when a particular combination, indication, or goal is off-label. Off-label does not mean automatically improper. It does mean the provider should be clear about what evidence exists and what remains uncertain.

Can hCG preserve sperm while a man stays on TRT?

It may help some men, but the evidence is not strong enough to promise protection.

Two often-cited studies show why the idea is plausible and why the claim must stay limited:

• A 2005 randomized study in 29 healthy men found that low-dose hCG maintained intratesticular testosterone during three weeks of testosterone-induced gonadotropin suppression. It measured a biological intermediate, not long-term sperm preservation, pregnancy, or live birth. (Coviello et al., 2005)
• A 2013 retrospective study of 26 hypogonadal men reported maintained semen parameters when low-dose hCG was used with TRT. It was small, nonrandomized, and not designed to prove that the combination protects every patient. (Hsieh et al., 2013)

The responsible conclusion is:

• hCG can support intratesticular testosterone;
• some men maintain sperm production while using hCG with TRT;
• semen monitoring is still required;
• normal serum testosterone does not show that hCG is protecting sperm;
• pregnancy should not be delayed based on a guarantee that recovery can be produced later; and
• a man actively trying to conceive may still be advised to discontinue exogenous testosterone under specialist supervision.

A clinic that calls its TRT-plus-hCG package “fertility guaranteed,” “fertility preserved,” or “zero shutdown” is making a claim the evidence does not support.

What to do if you are already on TRT and now want a child

Do not panic, and do not assume either of the two extremes—that you are permanently infertile or that stopping testosterone will fix everything in three months.

Step 1: Contact the testosterone prescriber

Tell the prescriber that conception is now an active goal. Ask for the treatment record, including:

• testosterone product and route;
• current and prior dose schedules;
• treatment start date and interruptions;
• hCG, clomiphene, aromatase-inhibitor, or other hormone use;
• pre-treatment and follow-up labs; and
• any semen analyses performed before or during therapy.

Bring that information to the fertility specialist.

Step 2: Arrange a formal semen analysis

The result may show:

• sperm within a potentially usable range;
• oligozoospermia;
• severe oligozoospermia;
• cryptozoospermia, where very few sperm are found only after detailed laboratory examination; or
• azoospermia.

An abnormal result often needs confirmation. A reproductive laboratory and specialist can determine whether additional processing, repeat collection, sperm banking, or further diagnostic work is appropriate.

Step 3: See a reproductive urologist or male-fertility specialist

TRT-associated suppression may be the obvious explanation, but it should not automatically be treated as the only explanation. A specialist may evaluate for:

• primary versus secondary hypogonadism;
• baseline testicular disease;
• varicocele or obstruction when relevant;
• pituitary disease;
• genetic causes in severe sperm abnormalities;
• medication and substance effects; and
• sexual or ejaculatory problems that affect the chance of conception.

Step 4: Make a coordinated medication plan

Depending on the diagnosis and urgency, a clinician may recommend stopping exogenous testosterone and may consider hCG, a SERM, FSH, an aromatase inhibitor, or another approach. That decision should account for the fact that low-testosterone symptoms can return when TRT is stopped.

Do not copy a dosing schedule from a forum, social-media post, or clinic advertisement. Drug selection, dose, duration, and monitoring can differ substantially between a man with secondary hypogonadism, a man with primary testicular failure, and a man recovering from nonprescribed anabolic steroids.

Step 5: Recheck semen on a clinically appropriate schedule

Sperm production changes over months, not days. A specialist will set repeat-testing intervals based on the initial result, treatment, hormone response, and time available. Repeated daily or weekly home tests cannot replace a formal semen analysis and do not accelerate biological recovery.

Step 6: Evaluate both partners at the same time when pregnancy is the goal

AUA/ASRM guidance recommends concurrent assessment of both partners in an infertile couple. Waiting a year for sperm to recover may be reasonable for one couple and a costly delay for another, depending on the pregnancy partner’s age, ovarian reserve, medical history, and prior fertility evaluation. (AUA/ASRM guideline, Part I)

Known testosterone exposure is a reason to seek targeted advice early rather than waiting silently through a generic infertility timeline.

What if the semen analysis shows azoospermia?

Azoospermia is a result, not a complete diagnosis.

The next questions are:

• Was the result confirmed with an appropriately processed repeat sample?
• Was sperm production normal before TRT?
• Are LH and FSH suppressed, elevated, or otherwise abnormal?
• Is the pattern consistent with medication-induced suppression, primary testicular failure, or an obstruction?
• Is there a history of anabolic steroids, undescended testes, infection, surgery, chemotherapy, radiation, or genetic disease?
• How urgent is the reproductive timeline?

TRT-associated gonadotropin suppression is often recoverable, but azoospermia should not be managed through a generic online “restart” package. A reproductive urologist can decide whether observation, medical stimulation, additional testing, sperm cryopreservation when sperm reappear, or surgical sperm retrieval with IVF/ICSI should be discussed.

What a fertility-aware TRT provider should do

A high-quality provider should:

• ask about current and future fertility before prescribing;
• explain that exogenous testosterone can cause severe sperm suppression or azoospermia;
• state clearly that TRT is not birth control;
• confirm symptoms and consistently low testosterone rather than treating one isolated result;
• investigate the cause of low testosterone;
• discuss baseline semen analysis when future fertility matters;
• refer to reproductive urology when conception is active or semen results are abnormal;
• disclose when hCG, clomiphene, an aromatase inhibitor, or a combination is being used off-label;
• explain the limits of the evidence rather than promising preservation or recovery; and
• use semen results—not testosterone levels alone—to assess sperm production.

Provider red flags

Be cautious when a clinic:

• never asks whether you want children;
• says infertility only occurs with “abuse,” not medically prescribed TRT;
• guarantees that hCG prevents shutdown;
• guarantees full recovery after stopping;
• calls testosterone a reliable male contraceptive;
• claims injections are the only route that affects sperm;
• starts treatment after one borderline or poorly timed testosterone test without a cause evaluation;
• sells a prewritten “fertility protocol” without semen testing or specialist access;
• treats a higher testosterone number as proof of better fertility;
• hides the off-label status of fertility-related medications; or
• discourages consultation with a reproductive urologist.

Questions to ask before signing up with a TRT clinic

1. How do you screen for current and future fertility goals?
2. Do you recommend a baseline semen analysis for patients who may want children later?
3. Who interprets an abnormal semen analysis?
4. Do you have a reproductive-urology referral pathway?
5. What exactly do you mean when you say you “preserve fertility”?
6. What evidence supports your use of hCG or a SERM with TRT?
7. Which uses are FDA-approved and which are off-label?
8. How do you monitor sperm production during treatment?
9. What happens if sperm concentration falls severely or reaches azoospermia?
10. How do you manage low-testosterone symptoms if exogenous testosterone must be stopped for conception?
11. Are fertility medications, semen analyses, specialist visits, and sperm storage included in the advertised price?
12. Will I receive my complete prescription, lab, and treatment records if I transfer care?

A clinic should be able to answer those questions without turning uncertainty into a sales pitch.

Frequently asked questions

Can TRT make a man infertile?

Yes. TRT can suppress sperm production enough to make conception difficult and can cause azoospermia. The effect is variable, so it should be treated as a material risk rather than an inevitable outcome.

Does TRT always cause azoospermia?

No. Some men reach azoospermia, some develop low sperm counts, and some retain meaningful sperm production. Because the response is unpredictable, continued ejaculation, normal semen appearance, testicle size, libido, or a high blood testosterone result cannot show that fertility is intact.

Is infertility from TRT permanent?

It is often reversible after exogenous testosterone is stopped, but the timeline and degree of recovery vary. Some men recover sperm within months; others take more than a year. A patient may recover detectable sperm without returning to his prior baseline or achieving pregnancy. Baseline testicular disease can limit recovery independently of TRT.

How long does sperm recovery take after stopping TRT?

Controlled hormonal-contraception studies found that many healthy men reached the study’s sperm-concentration threshold within 6 to 12 months, with additional recovery through 24 months. Those estimates are not a personal forecast for long-term TRT users. Age, duration of exposure, baseline fertility, diagnosis, and specialist treatment can change the course.

Can my partner get pregnant while I am on TRT?

Yes. TRT is not an approved or reliable contraceptive. Some men continue producing sperm, and suppression takes time. Use established contraception when pregnancy is not desired.

Can a blood test tell whether TRT has affected my fertility?

No. Testosterone, LH, and FSH help explain the hormonal state, but they do not count sperm. A semen analysis is required to assess sperm concentration, motility, volume, and other measured parameters.

Does normal semen volume mean my sperm count is normal?

No. Most semen volume comes from the seminal vesicles and prostate rather than from sperm themselves. An ejaculate can look normal even when sperm concentration is very low or no sperm are detected.

Are testosterone injections worse for fertility than gel?

Both can suppress LH, FSH, intratesticular testosterone, and spermatogenesis. The extent may differ between regimens and individuals, but no standard systemic TRT route should be described as guaranteed fertility-safe.

Does taking hCG with TRT guarantee that I will stay fertile?

No. hCG can support intratesticular testosterone and has helped some men maintain semen parameters, but the supporting studies are small and do not establish guaranteed sperm preservation, pregnancy, or live birth. Semen monitoring remains necessary.

Is clomiphene the same as TRT?

No. TRT supplies external testosterone and can suppress pituitary gonadotropins. Clomiphene changes estrogen feedback in an effort to increase endogenous LH and FSH. It is used off-label in men, does not work for every cause of hypogonadism, and has its own risks and monitoring needs.

Should I bank sperm before TRT?

It is reasonable to discuss when biological children may matter in the future, particularly when baseline sperm are present and long-term testosterone treatment is being considered. Cryopreservation is established technology, but it carries collection and storage costs and does not guarantee a pregnancy. A semen analysis and fertility specialist can help determine how useful banking is likely to be.

Can I bank sperm after starting TRT?

Possibly. If sperm are still present, a fertility laboratory may be able to freeze them. If the count is very low, the sample may be more suitable for IVF/ICSI than IUI. If no sperm are detected, a specialist can discuss recovery and other options.

Can low testosterone itself reduce fertility?

Yes, depending on the cause. Primary testicular disease can impair both testosterone and sperm production. Secondary hypogonadism can deprive the testes of LH and FSH. That does not make exogenous testosterone a fertility treatment; TRT can further suppress the signaling needed for sperm.

Can I take TRT while actively trying to conceive?

Major guidelines advise against exogenous testosterone in men actively pursuing fertility, and AUA/ASRM says testosterone monotherapy should not be prescribed to men interested in current or future fertility. A reproductive specialist can evaluate alternatives and the urgency of treatment.

Do fertility supplements reverse TRT suppression?

There is no supplement proven to reliably reverse testosterone-induced gonadotropin suppression. AUA/ASRM says the clinical utility of supplements such as antioxidants and vitamins for male infertility is questionable and that evidence is inadequate to recommend specific agents. Supplements should not delay semen testing or specialist care. (AUA/ASRM guideline, Part II)

Which specialist should I see?

A reproductive urologist, male-fertility urologist, or andrologist is usually the most directly relevant specialist for sperm production and TRT-associated infertility. An endocrinologist may be essential when pituitary or hypothalamic disease is suspected. A reproductive endocrinology and infertility clinic coordinates couple-level treatment and ART.

The bottom line

TRT can lower sperm production dramatically, including to azoospermia. It does not suppress every man enough to prevent pregnancy, so it is not birth control. Sperm often return after testosterone is stopped, but no honest provider can guarantee the timing, the final sperm count, natural conception, or a live birth.

The most protective steps happen before treatment:

1. confirm that low testosterone has been properly diagnosed;
2. identify the cause;
3. state current and future fertility goals;
4. obtain a baseline semen analysis when fertility may matter;
5. discuss sperm banking and non-testosterone approaches; and
6. involve a reproductive urologist when conception is active or the risk is unacceptable.

For broader treatment-risk questions, see TRT safety and monitoring. To compare possible care routes, use Find My TRT Path—but do not let a general provider comparison replace a male-fertility evaluation.

Evidence limits and editorial method

This page prioritizes clinical guidelines, official drug labeling, and original human studies. Evidence is strongest for the fact that exogenous testosterone suppresses gonadotropins and can suppress spermatogenesis. Evidence is weaker for predicting an individual recovery timeline and for claiming that hCG, clomiphene, aromatase inhibitors, or combinations will preserve fertility during ongoing TRT.

Important limitations:

• Much of the recovery literature comes from hormonal male-contraception studies, not long-term real-world TRT populations.
• Many fertility-restoration studies are retrospective and combine medication changes, making it difficult to isolate the effect of one drug.
• Semen outcomes are more commonly reported than pregnancy or live birth.
• “Fertility preservation” is sometimes used to mean maintained intratesticular testosterone, maintained sperm concentration, banked sperm, or an eventual pregnancy. Those endpoints must not be treated as interchangeable.
• No medication dose or protocol is provided because treatment depends on diagnosis, labs, semen results, comorbidities, and reproductive timing.

Evidence reviewed: September 2, 2026.

See our editorial standards, medical review policy, and medical disclaimer.

Sources

1. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
2. Endocrine Society. Statement on Testosterone Replacement Therapy. July 16, 2026.
3. American Urological Association. Testosterone Deficiency Guideline. Published 2018; reviewed and validity confirmed 2024.
4. American Urological Association and American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men. Updated through the 2024 amendment process.
5. AUA/ASRM Male Infertility Guideline, Part I: evaluation, reproductive history, and semen analysis.
6. AUA/ASRM Male Infertility Guideline, Part II: medical treatment, testosterone, hCG, SERMs, aromatase inhibitors, FSH, and ART.
7. European Association of Urology. Sexual and Reproductive Health Guideline: Male Hypogonadism. 2026 edition.
8. Liu PY, et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. The Lancet. 2006.
9. Kohn TP, et al. Age and duration of testosterone therapy predict time to return of sperm count after hCG therapy. Fertility and Sterility. 2017.
10. Coviello AD, et al. Low-dose hCG maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. Journal of Clinical Endocrinology & Metabolism. 2005.
11. Hsieh TC, et al. Concomitant hCG preserves spermatogenesis in men undergoing testosterone replacement therapy. Journal of Urology. 2013.
12. DailyMed. Pregnyl (chorionic gonadotropin) prescribing information.
13. DailyMed. Clomiphene citrate prescribing information.
14. DailyMed. GONAL-f (follitropin alfa) prescribing information, including selected male hypogonadotropic-hypogonadism indications.
15. American Society for Reproductive Medicine. Fertility preservation in patients with medical indications: a committee opinion. 2026.

Medical disclaimer

This page is for general education and does not diagnose infertility, confirm candidacy for testosterone therapy, or replace care from a licensed clinician. Do not start, stop, or change testosterone, hCG, clomiphene, an aromatase inhibitor, FSH, or any other prescription medication based on this article. Fertility evaluation and treatment should be individualized by qualified clinicians using your history, examination, hormone testing, semen results, partner factors, and reproductive goals.